Wegovy UK In Stock - Cheapest Price £69.00 | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy UK In Stock - Price From £69.00

Get Wegovy at the cheapest UK price from £69.00 — Save £20 off first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy UK In Stock: Private Prescription Access & Availability

Finding Wegovy UK in stock has become significantly easier in 2024, with Cured Pharmacy maintaining consistent availability of genuine semaglutide weight loss injections. As a UK-registered online pharmacy (GPhC 9012511), we provide transparent access to Wegovy through our qualified prescriber network, with most patients receiving their treatment within 24-48 hours of approval. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure clinical safety and regulatory compliance.

Current Wegovy UK In Stock Status & Availability

Wegovy UK in stock levels have stabilised considerably following the supply challenges of 2023, with Cured Pharmacy maintaining reliable inventory across all dosage strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg). The MHRA-licensed semaglutide injection is now available for private prescription through our online consultation service, which takes under three minutes to complete and is reviewed by UK-registered prescribers within hours[1].

Our stock monitoring system updates in real-time, ensuring patients receive accurate availability information before completing their clinical assessment. Unlike many UK pharmacies that experienced prolonged Wegovy shortages, we've established direct supply relationships with licensed wholesalers to maintain consistent stock levels. This means patients starting their weight loss programme or continuing maintenance doses can rely on uninterrupted treatment access, which is clinically important for optimal outcomes[2].

The current Wegovy UK in stock situation reflects improved manufacturing capacity from Novo Nordisk, combined with better distribution planning across the UK market. At £69.00 for starter doses, our pricing remains competitive whilst ensuring genuine, refrigerated-chain-protected medication reaches patients safely. Every Wegovy pen is verified for authenticity and stored under pharmaceutical-grade conditions before dispatch.

How to Get Wegovy UK In Stock Through Private Prescription

Accessing Wegovy UK in stock through Cured Pharmacy involves a straightforward three-step process designed to meet MHRA regulatory requirements whilst prioritising patient convenience. First, patients complete our online medical questionnaire covering weight history, current medications, cardiovascular health, and previous weight loss attempts. This assessment typically takes 2-3 minutes and provides our prescribers with essential clinical information[3].

Once submitted, a UK-registered prescriber reviews your assessment within 4-6 hours during business days. They evaluate your suitability for semaglutide based on NICE guidance, which recommends GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities. If approved, your prescription is issued electronically and sent directly to our dispensary team, who prepare your Wegovy order for next-day delivery.

The entire process from assessment to delivery typically completes within 24-48 hours, ensuring patients don't face unnecessary delays in starting their treatment. Our prescribers maintain ongoing clinical oversight, with follow-up consultations scheduled at appropriate intervals to monitor progress and adjust dosing as needed.

Clinical Assessment Requirements for Wegovy

UK prescribers assess several clinical factors before approving Wegovy UK in stock orders, including BMI calculation, medical history screening for thyroid conditions or pancreatitis, current medication interactions (particularly with insulin or sulfonylureas), and cardiovascular risk factors. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 cannot be prescribed semaglutide due to contraindication warnings from the MHRA[4].

The assessment also evaluates realistic weight loss expectations and commitment to lifestyle modifications. Clinical trials showed that Wegovy achieved an average weight reduction of 15% body weight over 68 weeks when combined with reduced-calorie diet and increased physical activity, but individual results vary significantly based on adherence and metabolic factors[1].

Wegovy UK In Stock Dosing Schedule & Treatment Progression

The Wegovy UK in stock range includes five dosage strengths designed for gradual dose escalation, which minimises gastrointestinal side effects whilst optimising weight loss efficacy. Patients begin with 0.25mg once weekly for four weeks, then progress to 0.5mg for four weeks, 1mg for four weeks, 1.7mg for four weeks, before reaching the maintenance dose of 2.4mg weekly[2].

This 16-week titration schedule is clinically important for tolerability. The STEP clinical trial programme demonstrated that gradual dose escalation significantly reduced the incidence of nausea, vomiting, and diarrhoea compared to faster titration protocols. Most patients who discontinue semaglutide do so within the first 8-12 weeks due to gastrointestinal effects, making the slower escalation approach essential for treatment persistence[3].

Cured Pharmacy stocks all five dosage strengths continuously, allowing seamless progression through the treatment protocol. Each pen contains four weekly doses at the specified strength, and our prescribers schedule automatic follow-up reminders to ensure patients order their next dose tier before running out. This continuity is crucial because interrupting semaglutide treatment often requires restarting the titration schedule from 0.25mg.

Managing Dose Escalation Side Effects

Common side effects during Wegovy UK in stock dose escalation include nausea (affecting approximately 44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%), with most symptoms resolving within 4-8 weeks as the body adapts[4]. Our clinical team advises eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week to maintain stable blood levels.

If side effects become intolerable at any dose level, prescribers may recommend remaining at the current dose for an additional 4 weeks before attempting escalation, or in some cases, stepping back to the previous dose temporarily. This flexible approach, supported by clinical evidence, helps more patients reach the therapeutic 2.4mg maintenance dose.

Treatment Type Frequency Starting Price
Wegovy (Semaglutide) GLP-1 injection Once weekly from £89.00
Mounjaro (Tirzepatide) GLP-1/GIP injection Once weekly from £145.00
Wegovy Oral Tablets Semaglutide pill Once daily from £83.00
Saxenda (Liraglutide) GLP-1 injection Once daily from £68.00
Orlistat Lipase inhibitor Three times daily from £32.00
Mysimba Combination tablet Twice daily from £125.95

Wegovy UK In Stock Pricing & Discount Codes

Wegovy UK in stock pricing at Cured Pharmacy starts from £69.00 per four-week supply, representing competitive value within the UK private prescription market. This transparent pricing structure means patients know their exact costs before completing the clinical assessment, with no hidden fees or consultation charges added during checkout.

New patients can access an additional £20 discount on their first order using code Weightlossnew, reducing the initial month's cost to £69.00. This introductory offer helps patients trial the medication during the initial 0.25mg phase whilst assessing their personal tolerability and response. Subsequent orders are priced at the standard £69.00 rate, though we periodically offer loyalty discounts for patients maintaining long-term treatment programmes.

The pricing covers the genuine MHRA-licensed Wegovy pen, prescriber review, dispensing by our GPhC-registered pharmacy team, and next-day delivery in discreet packaging. Compared to some UK providers charging upwards of £69.00 per month, our model prioritises accessibility whilst maintaining full regulatory compliance and clinical safety standards.

Wegovy UK In Stock Clinical Evidence & Weight Loss Outcomes

The clinical evidence supporting Wegovy UK in stock prescribing comes primarily from the STEP (Semaglutide Treatment Effect in People with obesity) trial programme, which enrolled over 4,500 adults across multiple international sites. STEP 1, the pivotal trial, demonstrated that participants receiving 2.4mg semaglutide weekly achieved an average weight loss of 14.9% of initial body weight at 68 weeks, compared to 2.4% in the placebo group[1].

Importantly, 86.4% of semaglutide participants achieved at least 5% weight loss (considered clinically significant), whilst 69.1% achieved at least 10% weight loss, and 50.5% achieved at least 15% weight loss. These outcomes significantly exceeded those seen with previous weight loss medications, positioning semaglutide as one of the most effective pharmacological interventions for obesity currently available in the UK[2].

Beyond weight reduction, STEP trials also measured improvements in cardiovascular risk factors, with participants showing significant reductions in waist circumference (average 13.5cm decrease), systolic blood pressure, and markers of glycaemic control including HbA1c levels. These metabolic benefits contribute to the overall health improvements associated with Wegovy treatment, though individual results vary based on adherence, baseline characteristics, and lifestyle modifications[3].

Long-Term Weight Maintenance with Wegovy

The STEP 4 trial specifically examined weight maintenance by randomising participants who had already lost weight on semaglutide to either continue treatment or switch to placebo. Those continuing Wegovy UK in stock treatment maintained their weight loss and lost an additional 7.9% over 48 weeks, whilst the placebo group regained 6.9% of their body weight[4].

This evidence demonstrates that semaglutide works as a long-term weight management medication rather than a short-term solution, with most weight regain occurring after discontinuation. Our prescribers discuss realistic treatment timelines during consultations, typically recommending a minimum 12-month commitment to achieve and consolidate meaningful weight loss before considering maintenance strategies.

Wegovy UK In Stock Safety Profile & Monitoring Requirements

Wegovy UK in stock safety monitoring follows MHRA post-marketing surveillance protocols, with prescribers required to assess patients for specific risk factors before and during treatment. The most significant safety consideration involves the theoretical risk of thyroid C-cell tumours, observed in rodent studies but not conclusively demonstrated in human populations. Nevertheless, patients with personal or family history of medullary thyroid carcinoma remain contraindicated[4].

Common adverse effects beyond gastrointestinal symptoms include injection site reactions (affecting approximately 6% of patients), fatigue, dizziness, and headache. Serious but rare risks include acute pancreatitis (estimated incidence 0.2-0.4%), gallbladder disease including cholelithiasis, and hypoglycaemia when used alongside insulin or sulfonylureas. Our prescribers screen for these risk factors during initial assessment and provide clear guidance on warning signs requiring medical attention[1].

Ongoing monitoring typically includes weight tracking, blood pressure measurements, and assessment of gastrointestinal tolerability at 4-week intervals during dose escalation. Patients with diabetes require more frequent monitoring due to potential changes in glycaemic control. Our clinical team remains available via phone (+44 116 4646009) for any safety concerns arising between scheduled follow-ups, ensuring responsive clinical support throughout treatment.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  4. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Wegovy UK in stock available without seeing a GP?
Yes, Wegovy UK in stock is available through our online private prescription service without needing a GP appointment. A UK-registered prescriber reviews your medical questionnaire and issues a prescription if clinically appropriate, typically within 4-6 hours.
How quickly can I receive Wegovy if it's in stock?
Most patients receive their Wegovy UK in stock order within 24-48 hours of prescription approval via next-day delivery. Orders approved before 3pm typically dispatch the same working day in discreet packaging.
Do you stock all Wegovy dosage strengths?
Yes, Cured Pharmacy maintains Wegovy UK in stock across all five dosage strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) to support the complete dose escalation schedule without interruption.
What's the total cost for a full Wegovy treatment course?
At £69.00 per four-week supply, a typical 12-month Wegovy UK in stock treatment course costs approximately £69.00 with an additional £20 discount available on your first order using code Weightlossnew.
Can I get Wegovy on the NHS instead of private prescription?
NHS Wegovy access is currently limited to specialist weight management services in some regions, with significant waiting lists. Private prescription through Cured Pharmacy offers immediate access subject to clinical suitability assessment.
How do I know the Wegovy in stock is genuine?
All Wegovy UK in stock at Cured Pharmacy is sourced exclusively from MHRA-licensed wholesalers, with full batch traceability and temperature-controlled storage. Every pen includes manufacturer verification features and patient information leaflets.
What happens if I experience side effects during treatment?
Our clinical team provides ongoing support throughout your Wegovy treatment. If side effects occur, prescribers can adjust your dose escalation schedule, provide management advice, or discontinue treatment if medically necessary.
Is Wegovy in stock suitable for everyone wanting to lose weight?
Wegovy UK in stock is licensed for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities. Prescribers assess individual suitability based on medical history, current medications, and contraindications during the online consultation.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.